Skip to main content
James Earls, MD, Radiology, Winchester, VA

JamesPEarlsMD

Radiology Winchester, VA

Abdominal Imaging, Cardiac CT & MRI

Chief Medical Officer, Cleerly Inc.

Dr. Earls is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Earls' full profile

Already have an account?

  • Office

    1840 Amherst St
    Winchester, VA 22601
    Phone+1 540-536-8750
    Fax+1 612-294-4903

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Radiology-Diagnostic, 1995 - 1996
  • National Capital Consortium
    National Capital ConsortiumResidency, Radiology-Diagnostic, 1990 - 1994
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1988 - 1989
  • New York University School of Medicine
    New York University School of MedicineClass of 1988

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1994 - Present
  • MD State Medical License
    MD State Medical License 1997 - 2026
  • VA State Medical License
    VA State Medical License 1999 - 2026
  • WV State Medical License
    WV State Medical License 2016 - 2026
  • KY State Medical License
    KY State Medical License 2018 - 2025
  • MI State Medical License
    MI State Medical License 2018 - 2025
  • NY State Medical License
    NY State Medical License 1995 - 2025
  • American Board of Radiology Diagnostic Radiology
  • Join now to see all

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification MedInformatix EHR, MedInformatix, Inc, 2013

Publications & Presentations

PubMed

Press Mentions

  • Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery Disease
    Results of CERTAIN Study Demonstrate Prominent Effects of Cleerly Products on Changing Clinical Management for Patients Suspected of Coronary Artery DiseaseFebruary 14th, 2024
  • Cleerly ISCHEMIA Software Device Billable with AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve
    Cleerly ISCHEMIA Software Device Billable with AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow ReserveFebruary 24th, 2024
  • Cleerly® ISCHEMIA™ Demonstrates Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical Trials
    Cleerly® ISCHEMIA™ Demonstrates Robust Diagnostic Accuracy and Prognostic Utility in Analyses from Large Scale Clinical TrialsMarch 29th, 2024